MARKET

EVOK

EVOK

Evoke Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.8331
-0.0169
-1.99%
Closed 16:00 10/23 EDT
OPEN
0.8700
PREV CLOSE
0.8500
HIGH
0.8735
LOW
0.8234
VOLUME
22.74K
TURNOVER
--
52 WEEK HIGH
3.260
52 WEEK LOW
0.5001
MARKET CAP
20.09M
P/E (TTM)
-2.1198
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of EVOK and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

EVOK News

  • Foamix Initiates Phase II Study on Acne Combination Foam
  • Zacks.09/20 22:14
  • When Will Evoke Pharma, Inc. (NASDAQ:EVOK) Come Back To Market?
  • Simply Wall St..09/19 17:02
  • Zynerba Releases Data on Epilepsy Candidate, Stock Down
  • Zacks.09/19 15:29
  • Evoke Pharma Completes Manufacturing of Commercial Scale Registration Batches of Gimoti
  • GlobeNewswire.09/17 13:30

More

Industry

Pharmaceuticals
-0.34%
Pharmaceuticals & Medical Research
-0.25%

Hot Stocks

Name
Price
%Change

About EVOK

Evoke Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases. The Company is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. EVK-001 is a formulation of Metoclopramide drug, designed to provide systemic delivery of metoclopramide through intranasal administration. The Company has evaluated EVK-001 in a multicenter, randomized, double-blind, placebo-controlled parallel group, dose-ranging Phase IIb clinical trial. The Company has commenced a Phase III clinical trial of EVK-001 in female patients with symptoms associated with acute and recurrent diabetic gastroparesis. The Phase III clinical trial is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study evaluating the efficacy, safety and population pharmacokinetics of EVK-001 in adult females.
More

Webull offers Evoke Pharma Inc (EVOK) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.